BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7079606)

  • 1. Immunogenicity of killed Bordetella bronchiseptica vaccines in the mouse.
    Smith IM; Baskerville AJ; Brothwell E; Oliphant J
    Res Vet Sci; 1982 Mar; 32(2):248-52. PubMed ID: 7079606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of an attenuated Bordetella bronchiseptica vaccine in pigs.
    Sakano T; Sakurai K; Furutani T; Shimizu T
    Am J Vet Res; 1984 Sep; 45(9):1814-7. PubMed ID: 6497138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
    Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
    Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral vaccination of young swine against Bordetella bronchiseptica.
    Farrington DO; Switzer WP
    Am J Vet Res; 1979 Oct; 40(10):1347-51. PubMed ID: 525851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):51-7. PubMed ID: 705049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epizootiological studies on porcine atrophic rhinitis. XV. Results of local immunization with a live Bordetella bronchiseptica strain in a large-scale pig herd affected by atrophic rhinitis.
    Eliás B; Gergely P; Boros G
    Acta Vet Hung; 1988; 36(3-4):195-204. PubMed ID: 2978213
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia.
    Matherne CM; Steffen EK; Wagner JE
    Lab Anim Sci; 1987 Apr; 37(2):191-4. PubMed ID: 3599889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of pigs against Bordetella bronchiseptica infection by parenteral vaccination.
    Harris DL; Switzer WP
    Am J Vet Res; 1972 Oct; 33(10):1975-84. PubMed ID: 4342331
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differentiation of Bordetella bronchiseptica strains. 2. Determination of protective properties of selected strains in a cross-protection test].
    Krüger M; Horsch F
    Arch Exp Veterinarmed; 1982; 36(5):699-702. PubMed ID: 7165454
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.
    Shade FJ; Goodnow RA
    Am J Vet Res; 1979 Sep; 40(9):1241-3. PubMed ID: 525927
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
    Bey RF; Shade FJ; Goodnow RA; Johnson RC
    Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative local and systemic immunization against experimentally-induced Bordetella bronchiseptica pneumonia in ICR mice].
    Müller G; Heilmann P
    Z Erkr Atmungsorgane; 1987; 169(2):136-46. PubMed ID: 3687105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agglutinin response of pigs to intranasal infection of Bordetella bronchiseptica.
    Kemeny LJ
    Cornell Vet; 1973 Jan; 63(1):130-7. PubMed ID: 4687068
    [No Abstract]   [Full Text] [Related]  

  • 20. Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs.
    Kang ML; Kang SG; Jiang HL; Guo DD; Lee DY; Rayamahji N; Seo YS; Cho CS; Yoo HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1179-85. PubMed ID: 18600065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.